- Home
- Applications
- canada alberta
- oncology
Oncology Product Applications Available In Alberta
33 applications found
Prancer RTSM? enables you to follow the science. Whether you have a simple, first-in-human study or complex dose escalation trials, our RTSM solutions provide the flexibility to adapt and scale alongside your Phase 1 trials. ...
By4G Clinical based in Wellesley, MASSACHUSETTS (USA)
4 Ways Digital Can Transform Treatment Selection in Oncology Expert insights on the challenges care teams face in pairing patients with oncology treatments and how digital health solutions can help New and innovative cancer treatments are coming to market faster than ever—a huge win for both patients and care teams. However, with the influx of new treatments also comes an “information avalanche.” Simply put, oncologists are struggling with the sheer volume of information they need to keep ...
ByBrightInsight, Inc based in San Jose, CALIFORNIA (USA)
Simplifying The Complexities of Modern Health ...
ByNantHealth, Inc. based in Morrisville, NORTH CAROLINA (USA)
AlNovo is pioneering new therapeutic modalities based on our Novobinder Platform to harness the power of the human immune system to directly attack cancer ...
ByAinovo Biotech Inc. based in Sacramento, CALIFORNIA (USA)
Sinus, Nasal, Maxillo-Facial, Mandibular, Aural, Brain, Trauma, Oncology, Neuro Angiography with SeeFactor ...
ByEpica Human Health based in Duncan, SOUTH DAKOTA (USA)
PLGA nanospheres have already been successfully used in vitro and in clinical trials. Results show that drugs encapsulated in PLGA nanoparticles have superior accumulation in the tumor environment, reduced tumor size and enhanced inhibition of cell proliferation. This is thanks to increased cell penetration and reduced toxicity of encapsulated compounds. Because of the higher accumulation in tumoral areas PLGA nanoparticles are also useful for cancer diagnosis and imaging which has a key role in clinical oncology ...
ByNanovex Biotechnologies based in Llanera, SPAIN
Palliative care needs are increasing and becoming more complex. Outcome measurement plays a major role in improving the quality, efficiency and availability of palliative care. Measuring these changes and causes in a patient’s health over time can help service providers focus on learning and improving the quality of ...
ByMaltron International Ltd based in Rayleigh, UNITED KINGDOM
Monitor quality of life and treatment effects to increase overall wellbeing. PROMs have become a prominent topic in healthcare innovation, especially in cancer care, via the direct evaluation of treatment outcomes from the patients' perspective. Patient-Reported Outcomes offer physicians a multitude of insights into cancer care processes through the perspective of the patient. Routine collection of PRO data in oncology can plan a pivotal role in improving clinical outcomes and the overall quality of ...
ByHeartbeat Medical based in Berlin, GERMANY
Data from examining the immune repertoire of cancer patients can be used to identify patterns associated with positive outcomes and monitor the progress of immunotherapies in clinical trials. Single cell immune sequencing technologies provide an even more granular view of individual T cell or B cell populations following immunotherapy, providing unprecedented detail for informing cancer ...
ByiRepertoire, Inc. based in Huntsville, ALABAMA (USA)
For the world’s leading radiation oncologists, cancer treatment has changed dramatically in recent years. Electron beam technology is becoming more precise, more portable and more efficient. And the interaction and collaboration with surgical teams in the OR has meant that radiation treatment has entered a new era. An era where the procedure is successfully administered in ...
ByIntraOp Medical, Inc. based in Sunnyvale, CALIFORNIA (USA)
Natural killer (NK) cells have long been known to play a significant role in the body’s innate immune response. They were first described in the 1970s, but only in the last 15 years has significant progress been made in understanding the complexities and therapeutic potential these cells offer in helping fight cancer and other diseases. Today, we know that NK cells not only detect and identify malignant cancer cells, but they also induce cancer cell death and even help trigger a broader adaptive immune ...
ByKiadis Pharma NV based in Amsterdam, NETHERLANDS
Cancer is one of the leading causes of deaths in India and a major public health concern. It is estimated that there are around 1 million new cancer cases every year and as many as 5 lakh deaths occur annually. Around 71% of all cancer deaths in India occur in people 30 to 69 years of age, when adults are very productive. The burden of cancer is expected to further increase due to increase in life expectancy, heavy use of tobacco and other risk factors such as radiation, viruses, ...
ByinDNA Research Labs based in , INDIA
The increasing volume of data for managing medical imaging information in conjunction with the international and national regulations for storage of data can now easily be managed using Picture Archiving and Communication Systems(PACS). The digital management of medical data allows the distribution, digitization (DICOM) and procession of medical images, for specific clinical applications (oncology, radiology, cardiology, etc.) as well as for their backup ...
ByBiotexray S.A based in Athens, GREECE
The endocrine and metabolic system includes endocrine glands and endocrine tissues, which regulate human function by secreting hormones. Endocrine diseases are rare and often very difficult to diagnose and treat. Among the 121 rare diseases included on China’s national list of rare diseases in 2018, more than 20 are endocrine/metabolic-related rare ...
ByRareStone Group based in Shanghai, CHINA
Microbiotica is using best-in-class clinical data and sample sets coupled with its unrivalled microbiome profiling capability to progress best-in-class therapeutics and biomarkers. Microbiotica has programs in IBD, Immuno-oncology and Gut Epithelial Barrier Repair developing medicines and biomarkers based on microbiota. These programs start with deep metagenomic and culture-based analysis of patient samples and involve advanced bioinformatics and machine learning, to identify highly significant bacterial ...
ByMicrobiotica Limited based in Little Chesterford, UNITED KINGDOM
All your data in one place. Athelas delivers patient vitals into 80+ EHRs including Epic, Cerner and Athena. Seamlessly integrate RPM datapoints into your existing protocols for patient care and maximize clinical ...
ByAthelas Incorporated based in Mountain View, CALIFORNIA (USA)
The IntraOp® Mobetron® is the most comprehensive electron therapy linear accelerator system with applications in intraoperative radiotherapy (IORT) and non-invasive treatment of skin cancer. Now Mobetron is the first to offer ultra-high dose rate electron therapy for preclinical and investigational studies of FLASH radiotherapy on an established clinical radiotherapy platform. IntraOp’s advanced technology ushers in a new paradigm for cancer treatment by providing researchers an approach not possible ...
ByIntraOp Medical, Inc. based in Sunnyvale, CALIFORNIA (USA)
IntraOp® Mobetron® saves time and enables more treatments in the operating room. It increases productivity and enhances collaboration among surgical and radiation oncologists. Breast cancer treatment with IORT is precise and flexible. The patient experience and outcomes are better. The data is conclusive and ASTRO ...
ByIntraOp Medical, Inc. based in Sunnyvale, CALIFORNIA (USA)
The reputation of your cancer treatment facility hinges on your ability to recruit world-class oncologists. Those who can collaborate to leverage pioneering technologies and therapies for the benefit of their patients. It’s an investment in talent and technology. And your technology must be proven, precise and ...
ByIntraOp Medical, Inc. based in Sunnyvale, CALIFORNIA (USA)
You likely already know that electron-beam IORT has been successfully treating multiple cancer indications for nearly 50 years and has been treating breast cancer since the early 1990’s. The first accelerated partial breast irradiation (APBI) treatment with the IntraOp® Mobetron® was performed in 2006. Today, more than 20,000 women have been treated with electron IORT demonstrating equivalency in local control with reduced toxicity and improved cosmesis. More than 10,000 breast cancer patients have ...
ByIntraOp Medical, Inc. based in Sunnyvale, CALIFORNIA (USA)